Ondine Biomedical Share Discussion Threads

[z1co] 16/5/2024 12:06

The company ended last year with 16 hospital deployments, up from six at the prior year end.A lot of deployments in Q3 and Q4.

This year they started with Steriwave used as a standard by 16 hospitals and in Q1 they added 8 more hospitals.

In April Steriwave was also authorised for use by HCA UK.

HCA Healthcare is the largest private healthcare provider in the world, and one of the leading private healthcare providers in the UK, where it operates over 30 healthcare facilities.

Last year revenue increased by 100% to $1.2m , revenue for the current year is likely to increase significantly higher 100% taking in to account how fast Steriwave is beginning to be deployed all over the world.

[jailbird] 16/5/2024 11:49

Zico,

You keep spouting repeat info..tell me something new

How much revenue do they need to become cashflow positive, maybe next year after USA FDA trials

Will not be this year as need to raise later this year

[z1co] 16/5/2024 11:46

The company ended last year with 16 hospital deployments, up from six at the prior year end.A lot of deployments in Q3 and Q4.

This year they started with Steriwave used as a standard by 16 hospitals and in Q1 they added 8 more hospitals.

In April Steriwave was also authorised for use by HCA UK.

HCA Healthcare is the largest private healthcare provider in the world, and one of the leading private healthcare providers in the UK, where it operates over 30 healthcare facilities.

Last year revenue increased by 100% to $1.2m , revenue for the current year is likely to increase significantly higher 100% taking in to account how fast Steriwave is beginning to be deployed all over the world.

[z1co] 16/5/2024 11:43

Hey CLOWN read the post above , what are other users are saying about you.

[purple11] 16/5/2024 11:41

ive had the same username for 14 years

my record is there for everyone to see on the CR Thread

i certainly wont be changing it for some complete nobody like you!hahahah

[z1co] 16/5/2024 11:38

Other users have sussed you out.

Idiot change your user name

[purple11] 16/5/2024 11:21

OBI dropped 50% recently because punters knew a placing was coming

well.....it is due ANOTHER placing in the next 3 months

what will that be priced at and how dilutive will that be?

the last placing was 22% dilution.

theres no rush to buy

[purple11] 16/5/2024 11:17

you told us how wonderful OBI was at 10p

it then halved in price!

now youre saying it again.....whos to say it wont halve in price again?

[purple11] 16/5/2024 11:15

how much PROFIT is OBI making at the moment?
And how much is OBI diluting its stock at present?

LOL

[z1co] 16/5/2024 11:08

At 6.75p the company is valued at less than £13m , taking in to account that Steriwave is beginning to replace Mupirocin , the market cap is very very low and could easily reach £100m withing the next 12 months.

Mupirocin has been used by the hospitals for nearly 50 years , so for Steriwave to start replacing this a massive achievement by this tiny company.

[marvelman] 16/5/2024 10:38

Pots and kettles come to mind reading that Purple. You surely must admit to being, at the very least, inconsistent with your view of this company.

[z1co] 16/5/2024 10:37

A groundbreaking study in the UK has revealed a significant reduction in the need for antibiotics after sinus surgeries, thanks to a pioneering treatment called Steriwave.

Professor Claire Hopkins, a specialist in rhinology from King's College London and a consultant ENT surgeon at Guy's & St Thomas' NHS Foundation Trust, conducted the analysis.

She found that incorporating Steriwave for nasal decolonisation before endoscopic sinus surgery led to a 77% decrease in antibiotic usage. This means antibiotic use among her patients fell from 22% to just under 5%.

Since 2021, Professor Hopkins has been applying Steriwave as a standard procedure for her patients at London Bridge Hospital.

She said: "I was amazed that studies show that by treating the nose you can reduce spinal surgical site infections - so it seemed an ideal way to reduce the risk of post-operative infection after nasal surgery.

"I have seen a significant reduction in post-operative infections requiring antibiotics, which is good for the patients, reducing the risk of antibiotic-related side effects, and important to help prevent ever-increasing antibiotic resistance.

"It needs formal controlled studies to further evaluate the effectiveness but I am impressed with the difference that I have seen in my practice."

Ondine CEO Carolyn Cross welcomed the findings, which build on a significant and growing data set being compiled around the real-world use of Steriwave.

She told investors: "In an era of rising drug resistance, antibiotic stewardship is of great importance. Sinus surgery is typically associated with high rates of routine post-operative antibiotic prescribing in order to reduce the risk of post-operative infection.

"Reducing antibiotic usage is important to curb rising antimicrobial resistance and preserve antibiotics' effectiveness when there is no other solution.

"We are pleased to be supporting Professor Hopkins' development and adoption of important new infection control procedures that enable a marked reduction in antibiotic use in sinus surgery patients."

[z1co] 14/5/2024 11:27

In Q1 several hospitals announced expansions to include other surgical indications.

The Company is also benefitting from significantly reduced sales cycle times, lower new client acquisition costs and improved margins resulting from lower cost of goods and higher product pricing.

Also in the last quarter five hospitals outside of Canada have take up Steriwave , in the UK , Spain and Australia.

Steriwave in 2024 is starting to gain traction and more hospitals will start to replace the standard Mupirocin with Steriwave.

[purple11] 14/5/2024 04:52

considering how many hospitals there are in the world, Steriwave is used in a miniscule number of them.

wether it ever gains traction and spreads throughout the estate is a bit like a pipe dream.
in the 10 years it has been out for so far its used in a tiny number of hospitals and makes no money

in the meantime continual heavy dilution here could see a total collapse in the shareprice to 1p.

its clearly still in a downtrend and chancers like Zico will be long gone ,leaving you holding the baby as soon as it drops 10%so take their posts with a pinch of salt.he is not to be trusted.atb

[purple11] 13/5/2024 13:59

absolutely no interest here from the Retail community thus far.......

[z1co] 13/5/2024 09:02

Thanks marvelman

As well the 24 hospitals Steriwave has also been authorised to be used in the UK by HCA Healthcare UK.

HCA Healthcare is the largest private healthcare provider in the world, and one of the leading private healthcare providers in the UK, where it operates over 30 healthcare facilities.

Momentum for Steriwave in 2024 is picking up very strongly.

[marvelman] 13/5/2024 06:35

BBC news...well spotted Zico